Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 4
Submit an article Journal homepage
404
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Research

SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia

Limei XuDepartment of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; ;Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; View further author information
,
Mingming ZhangDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; View further author information
,
Hui LiDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; View further author information
,
Wen GuanDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; View further author information
,
Bin LiuDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; View further author information
,
Fengqi LiuDepartment of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; View further author information
,
Hehua WangDepartment of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; View further author information
,
Juan LiDepartment of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; View further author information
,
Shulan YangCentre for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; View further author information
,
Xiuzhen TongDepartment of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Correspondence[email protected]
View further author information
&
Haihe WangDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; ;Center for Stem Cell Biology and Tissue Engineering, Key Laboratory of Ministry of Education, Sun Yat-sen University, Guangzhou, China; ;Guangdong Engineering and Technology Research Center for Disease-Model Animals, Sun Yat-sen University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 918-930 | Received 08 Jan 2017, Accepted 10 Jun 2017, Published online: 06 Jul 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shaoyang Zhang, Xiufeng Liu, Saleh Abdulmomen Ali Mohammed, Hui Li, Wanhua Cai, Wen Guan, Daiyun Liu, Yanli Wei, Dade Rong, Ying Fang, Farhan Haider, Haimei Lv, Ziwei Jin, Xiaomin Chen, Zhuomao Mo, Lujie Li, Shulan Yang & Haihe Wang. (2022) Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers. Autophagy 18:8, pages 1822-1840.
Read now

Articles from other publishers (11)

Ziwei Jin, Dongxia Wang, Haimei Lv, Bo Wu, Zhe Li, Xiaoling Guo, Haihe Wang & Shulan Yang. (2023) Loss of the adaptor protein Sh3bgrl initiates ovarian fibrosis in zebrafish. FEBS Letters 597:21, pages 2643-2655.
Crossref
Abdulmomen Ali Mohammed Saleh, Farhan Haider, Haimei Lv, Bin Liu, Jing Xiao, Mingming Zhang, Yuzhen Zheng, Shulan Yang & Haihe Wang. (2023) SH3BGRL Suppresses Liver Tumor Progression through Enhanced ATG5-Dependent Autophagy. Journal of Oncology 2023, pages 1-13.
Crossref
Ying Chen, Jiajun Qiu, Yingwei Wu, Huan Jia, Yi Jiang, Mengda Jiang, Zhili Wang, Hai-Bin Sheng, Lingxiang Hu, Zhihua Zhang, Zhaoyan Wang, Yun Li, Zhiwu Huang & Hao Wu. (2022) Genetic findings of Sanger and nanopore single-molecule sequencing in patients with X-linked hearing loss and incomplete partition type III. Orphanet Journal of Rare Diseases 17:1.
Crossref
Xiaomin Chen, Fengqi Liu, Dade Rong, Limei Xu, Xiuzhen Tong & Haihe Wang. (2022) Decitabine Enhances Acute Myeloid Leukemia Cell Apoptosis through SH3BGRL Upregulation. Anti-Cancer Agents in Medicinal Chemistry 22:12, pages 2274-2281.
Crossref
Shaoyang Zhang, Xuemin Guo, Xiufeng Liu, Zhixiong Zhong, Shulan Yang & Haihe Wang. (2021) Adaptor SH3BGRL promotes breast cancer metastasis through PFN1 degradation by translational STUB1 upregulation. Oncogene 40:38, pages 5677-5690.
Crossref
Zhi Nie, Dating Cheng, Chenglong Pan, Zhimin Wei, Chenyang Wang & Chunyan Wang. (2021) SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling. Biochemical and Biophysical Research Communications 556, pages 114-120.
Crossref
Zhiping Liu, Wen Xu, Xiansheng Tan & Chunhua Li. (2021) EZH2-mediated epigenetic suppression of SH3BGRL potently inhibits lung cancer progression. Biochemical and Biophysical Research Communications 548, pages 53-59.
Crossref
Zhi Nie, Shan Cai, Zhimin Wei, Yanxi Li, Li Bian, Chenyang Wang & Chunyan Wang. (2021) SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis. Biochemical and Biophysical Research Communications 547, pages 148-154.
Crossref
Hui Li, Mingming Zhang, Yanli Wei, Farhan Haider, Yitong Lin, Wen Guan, Yanbin Liu, Shaoyang Zhang, Ronghua Yuan, Xia Yang, Shulan Yang & Haihe Wang. (2020) SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Maeva Dufies. (2020) SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas. EBioMedicine 52, pages 102641.
Crossref
Lei Yin, Wenjia Li, Aiming Xu, Heng Shi, Keyi Wang, Huan Yang, Ronghao Wang & Bo Peng. (2020) SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. EBioMedicine 51, pages 102596.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.